Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07000851 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Imaging Studies in Corticobasal Syndrome

Study acronym: I-CAN
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv5
  2. Start date changed from estimate of Jun 2025 to Jun 25, 2025v4
  3. Start date: Jun 1, 2025 to Jun 2025v3
  4. Primary endpoint revised
    • Eligibility criteria shortened, about 62 words
    • Secondary endpoint revised
    • Study description expanded, about 4 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary goal of this study is to investigate inflammation and white matter damage in corticobasal syndrome and determine whether these processes are related to each other. The investigator's will address our goal by using neuroimaging and blood plasma biomarkers, as well as molecular pathology.
Trial Details
NCT Number NCT07000851
Lead Sponsor Jennifer Whitwell
Collaborators: National Institute on Aging (NIA)
Conditions
(from sponsor)		 Cortico Basal Degeneration, Corticobasal Syndrome, Corticobasal Syndrome(CBS), Corticobasal Degeneration, Corticobasal Degeneration (CBD), Corticobasal Syndrome (CBS)
Related terms Color Vision Defects, Corticobasal Degeneration, Nerve Degeneration, Neurodegenerative Diseases
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov